Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-03-02

Clinical Trial Update: Pancreatic Enzyme Replacement in Acute Necrotizing Pancreatitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing pancreatic enzyme replacement for acute necrotizing pancreatitis and pancreatic exocrine insufficiency is currently not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pancreatic enzyme replacement therapy (pancreatic enzyme replacement therapy)

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: Acute Necrotizing Pancreatitis, Pancreatic Exocrine Insufficiency | Phase 3 | Status: NOT_YET_RECRUITING